Taurine 5 pp 445-451 | Cite as

Interactions of Taurine and Adenosine in the Mouse Hippocampus in Normoxia and Ischemia

  • Pirjo Saransaari
  • Simo S. Oja
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 526)


Adenosine acts as an inhibitory neuromodulator in the brain through three types of receptors, namely A1, A2, (two subtypes A2A and A2B), and A31. By means of presynaptic A1 receptors adenosine inhibits neurotransmitter release mainly in excitatory synapses, reducing thus neuronal excitability2. Postsynaptically, adenosine hyperpolarizes the postsynaptic membrane through A, receptors by increasing Ca2+ -dependent K+ conductance. Depolarization with K+, electrical stimulation and various agents, including ionotropic glutamate receptor agonists, induce adenosine release 2. Furthermore, adenosine is released during hypoxia and ischemia3, acting then as an endogenous neuroprotectant against cerebral ischemia and excitotoxic neuronal damage4. Similar neuroprotective effects have also been assigned to taurine, a putative inhibitory neuromodulator5, which is also released from nervous tissue under various cell-damaging conditions6. Being particularly enriched in the brain of immature animals, taurine has been thought to have a special function, being essential for the development and survival of neural cells7.8. We now characterized interactions in the release of taurine and adenosine from hippocampal slices from developing (7-day-old) and adult (3month-old) mice in normal conditions and in ischemia, using a superfusion system7.


Adenosine Receptor Hippocampal Slice Adult Hippocampus Adenosine Receptor Agonist Taurine Release 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cunha, R.A., 2001, Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int. 38:107–125.PubMedCrossRefGoogle Scholar
  2. 2.
    Latini, S., and Pedata, F., 2001, Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79:463–484.PubMedCrossRefGoogle Scholar
  3. 3.
    Rudolphi, K.A., Schubert, P., Parkinson, F.E., and Fredholm, B.B., 1992, Adenosine and brain ischemia. Cerebrovasc. Brain Metab. Rev. 4:34.6–369.Google Scholar
  4. 4.
    Deckert, J., and Gleiter, C.H., 1994, Adenosine — an endogenous neuroprotective metabolite and neuromodulator. J. Neural Transm. 43:Suppl., 23–31.Google Scholar
  5. 5.
    Oja, S.S., and Saransaari, P., 1996, Taurine as osmoregulator and neuromodulator in the brain. Metab. Brain Res. 11, 153–164.CrossRefGoogle Scholar
  6. 6.
    Saransaari, P., and Oja, S.S., 2000, Taurine and neural cell damage. Amino Acids 19:509–526.PubMedCrossRefGoogle Scholar
  7. 7.
    Kontro, P., and Oja, S.S., 1987, Taurine and GABA release from mouse cerebral cortex slices: potassium stimulation releases more taurine than GABA from developing brain. Dev. Brain Res. 37:277–291.CrossRefGoogle Scholar
  8. 8.
    Sturman, J.A., 1993, Taurine in development. Physiol. Rev. 73:119–147.PubMedGoogle Scholar
  9. 9.
    Cunha, R.A., Johansson, B., Van der Ploeg, I., Sebastiao, A.M., Ribeiro, J.A., and Fredholm, B.B., 1994, Evidence for functionally important adenosine A2A receptors in the rat hippocampus. Brain Res. 649, 208–216.PubMedCrossRefGoogle Scholar
  10. 10.
    Psarropoulou, C., Kostopoulos, G., and Haas, H.L., 1990, An electrophysiological study of the ontogenesis of adenosine receptors in the CA 1 area of rat hippocampus. Dev. Brain Res. 55:147–150.CrossRefGoogle Scholar
  11. 11.
    Sebastian, A.M., Stone, T.W., and Ribeiro, J.A., 1990, The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br. J. Pharmac. 101:453–459.CrossRefGoogle Scholar
  12. 12.
    Sebastian, A.M., and Ribeiro, J.A., 1992, Evidence for the presence of excitatory A2 adenosine receptors in the rat hippocampus. Neurosci. Len. 138:41–44.CrossRefGoogle Scholar
  13. 13.
    Fredholm, B.B., and Dunwiddie, T.V., 1988, How does adenosine inhibit transmitter release? Trends Pharmac. Sci. 9:130–134.CrossRefGoogle Scholar
  14. 14.
    Ribeiro, J.A., 1999, Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators. Eur. J. Pharmac. 375:101–113.CrossRefGoogle Scholar
  15. 15.
    Corsi, C., Melani, A., Bianchi, L., Pepeu, G., and Pedata, F., 1999, Striatal A2A adenosine receptors differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats. Neuroreport 10:687–691.PubMedCrossRefGoogle Scholar
  16. 16.
    Saransaari, P., and Oja, S.S., 2000, Modulation of the ischemia-induced taurine release by adenosine receptors in the developing and adult mouse hippocampus. Neuroscience 97:425430.Google Scholar
  17. 17.
    Saransaari, P., and Oja, S.S., 1998, Mechanisms of ischemia-induced taurine release in mouse hippocampal slices. Brain Res. 807:118–124.PubMedCrossRefGoogle Scholar
  18. 18.
    Goda, H., Ooboshi, H., Nakane, H., Ibyashi, S., Sadoshima, S., and Fujishima, M., 1998, Modulation of ischemia-evoked release of excitatory and inhibitory amino acids by adenosine Al receptor agonist. Eur. J. Pharmac. 357:149–155.CrossRefGoogle Scholar
  19. 19.
    Saransaari, P., and Oja, S.S., 2002, Mechanisms of adenosine release in the developing and adult mouse hippocampus. Neurochem Res. 27:911–918.PubMedCrossRefGoogle Scholar
  20. 20.
    Saransaari, P., and Oja, S.S., 1999, Characteristics of ischemia-induced taurine release in the developing mouse hippocampus. Neuroscience 94:949–954.PubMedCrossRefGoogle Scholar
  21. 21.
    Saransaari, P., and Oja, S.S., 2002, Characterization of N-methyl-D-aspartate-evoked taurine release in the developing and adult mouse hippocampus. Amino Acids DOI 10.1007/s00726–002–0310-z.Google Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Pirjo Saransaari
    • 1
  • Simo S. Oja
    • 1
    • 2
  1. 1.Tampere Brain Research Center, Medical SchoolUniversity of TampereFinland
  2. 2.Department of Clinical PhysiologyTampere University HospitalTampereFinland

Personalised recommendations